Global Oral Acarbose Market Insights, Forecast to 2028

Acarbose is a kind of API that is white powder,It is used to product such as acarbose tablets/acarbose capsules/acarbose chewable tablets，which is a kind ofα - glucosidase inhibitor procucts. The medicine used drugs for type 2 diabetes, which is a pseudo-four sugar biosynthesis, can inhibit the small intestine cells activity of α - glucosidase, thereby delaying intestinal oligosaccharide, disaccharide or polysaccharide degradation, delaying the degradation and absorption of glucose and fructose in order to achieve the effect of reducing postprandial blood glucose.
Market Analysis and Insights: Global Oral Acarbose Market
Due to the COVID-19 pandemic, the global Oral Acarbose market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Acarbose Tablets accounting for % of the Oral Acarbose global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Oral Acarbose market size is valued at US$ million in 2021, while the US and Europe Oral Acarbose are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Acarbose landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Oral Acarbose include Bayer, CKDBioCorporation, Hangzhou East China Pharmaceutical, Livzon Pharmaceutical Group, Hebei Huarong Pharmaceutical, Zhejiang Hisun Pharmaceutical and Zhebei Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oral Acarbose Scope and Segment
Oral Acarbose market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Acarbose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Acarbose Tablets
Acarbose Capsules
Acarbose Chewable Tablets
Segment by Application
Hospital
Clinic
By Company
Bayer
CKDBioCorporation
Hangzhou East China Pharmaceutical
Livzon Pharmaceutical Group
Hebei Huarong Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhebei Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE